Alnylam Pharmaceuticals has agreed to drop its 2023 patent lawsuit against Moderna in a Delaware court following a judge's ...

What’s left of Johnson & Johnson’s infectious disease work continues to shrink, after the company announced Friday that it ...

The weather is getting cooler, but biotech’s recovery is heating up. After a years-long wait-and-see game exhausted many ...

Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week. The ...

Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million ...

Telehealth companies and patients are grappling with the potential loss of access to cheaper, alternative versions of Eli ...

WuXi AppTec and WuXi Biologics are reportedly looking to sell part of their operations that have struggled because of ...

The FDA's Center for Drug Evaluation and Research on Wednesday officially launched a new center of excellence to better ...

The UK’s publicly funded healthcare system has proposed phasing its rollout of Eli Lilly’s weight loss treatment tirzepatide ...

Relay Therapeutics is laying off 10% of its staff, or about 30 employees, in an additional round of job cuts after a smaller ...

DRI Healthcare Trust is paying $57 million upfront to the gene editing company in exchange for future licensing payments from Vertex, which struck an agreement with Editas to use its CRISPR/Cas9 gene ...